AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FOSAPREPITANT DIMEGLUMINE
7 registrations across 5 African markets— 7 active
Markets with FOSAPREPITANT DIMEGLUMINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FOSAP. Injection | 🇷🇼Rwanda | ASPIRO PHARMA LIMITED | active | Aug 2029 |
| APRITANT IV POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MSN LABORATORIES LTD | active | Aug 2029 |
| FOSAPREPITANT DIMEGLUMINE POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Dec 2027 |
| NAUSAP 150 IV | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Nov 2027 |
| FOSAP INJECTION (Each vial contains Fosaprepitant Dimeglumine 150mg) | 🇬🇭Ghana | — | active | Apr 2027 |
| FOSAP INJECTION (Each vial contains Fosaprepitant Dimeglumine 150mg) | 🇬🇭Ghana | — | active | Apr 2027 |
| FOSAP Injection | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
FOSAPREPITANT DIMEGLUMINE in Africa — Regulatory Overview
FOSAPREPITANT DIMEGLUMINE is registered across 5 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Zimbabwe, Rwanda, Tanzania and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.